Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Jun 18:7:34.
doi: 10.1186/1749-8090-7-34.

Treatment of 28 patients with sclerosing hemangioma (SH) of the lung

Yang Lei  1 , Duan Yong, Ruan Jun-Zhong, Yang Zhi, Wang Zi-Tong
Affiliations

Treatment of 28 patients with sclerosing hemangioma (SH) of the lung

Yang Lei et al. J Cardiothorac Surg. .

Abstract

Background: Sclerosing hemangioma (SH) of the lung is a kind of rare pulmonary tumor. Preoperative diagnosis of this tumor is difficult and it is now generally accepted that SH of the lung is benign lesions and surgical excision alone is curative. Herein, we present our experiences of treating 28 patients with SH.

Methods: The medical records of 28 patients with SH from 1994 to 2010 at the Department of Thoracic Surgery in Beijing Chest Hospital were retrospectively reviewed.

Results: There were 3 male and 25 female patients with sclerosing hemangioma and 50% of the patients were asymptomatic. Preoperatively, all the patients had undergone CT of chest and 5 patients had undergone PET scan but 4 patients were misdiagnosed as malignancy. There was no operative mortality or tumor recurrence despite that three different operative methods were undertaken.

Conclusions: SH has a high incidence in middle-aged women. Most of SH is asymptomatic and the symptoms of SH are not related to the tumor size and distribution. The features of chest CT and PET are not specific. Bilateral or multiple lesions should not exclude the possibility of SH. Complete excision of lesion is a curable treatment method and there is no evidence to verify the need of adjuvant therapy.

PubMed Disclaimer

References

    1. Liebow AA, Hubbell DS. Sclerosing hemangioma (histiocytoma, xanthoma) of the lung. Cancer. 1956;9(1):53–75. doi: 10.1002/1097-0142(195601/02)9:1<53::AID-CNCR2820090104>3.0.CO;2-U. - DOI - PubMed
    1. Devouassoux-Shisheboran M, Hayashi T, Linnoila RI, Koss MN, Travis WD. A clinicopathologic study of 100 cases of pulmonary sclerosing hemangiomawith immunohistochemical studies: TTF-1 is expressed in both round and surface cells suggesting an origin from primitive respiratory epithelium. Am J Surg Pathol. 2000;24:906–916. doi: 10.1097/00000478-200007000-00002. - DOI - PubMed
    1. Illei PB, Rosai J, Klimstra DS. Expression of thyroid transcription factor-1 and other markers in sclerosing hemangioma of the lung. Arch Pathol Lab Med. 2001;125:1335–1339. - PubMed
    1. Chan AC, Chan JK. Pulmonary sclerosing hemangioma consistently expresses thyroid transcription factor-1 (TTF-1): a new clue to its histogenesis. Am J Surg Pathol. 2000;24:1531–1536. doi: 10.1097/00000478-200011000-00009. - DOI - PubMed
    1. Kuo KT, Hsu WH, Wu YC, Huang MH, Li WY. Sclerosing hemangioma of the lung: an analysis of 44 cases. J Chin Med Assoc. 2003;66(1):33–38. - PubMed

LinkOut - more resources